Ablexis Status
The company was acquired by Deerfield Management through an LBO on June 21, 2018 for an undisclosed sum.
Provider of a drug discovery platform designed to broaden enablement of the efficient discovery of the next generation of breakthrough antibody drugs. The company's AlivaMab Mouse platform is an innovative, next-generation transgenic mouse platform, enabling biotechnology and pharmaceutical companies to efficiently discover and develop the next generation of human therapeutic antibodies to treat human diseases.
Year Founded
2009
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Venture Capital-Backed
Ablexis News and Updates
Mice Models Market 2021-2026 : Competitive Study | Charles River Laboratories, The Jackson Laboratories, Taconic Farms International
NeighborWebSJ | January 18, 2021
Mice Model Market 2021 Regional Growth To 2027 By Top Players: | Charles River Laboratories, The Jackson Laboratories, Taconic Farms International
Splash Radio Wales | January 18, 2021
Ablexis Announces Further Expansion of Its Intellectual Property on AlivaMab® Mouse and Immunoglobulin Locus Engineering
Business Wire | October 15, 2020
Global Mice Model Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast
AlgosOnline | September 28, 2020
Ablexis's Verticals
Ablexis Primary Industry Sector / Group / Code
Ablexis's Trends
Ablexis Metrics
Growth Rate
SimilarWeb Unique Visitors
Headquarters
-
HQ Address Line 1409 Illinois Street
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94158
-
HQ CountryUnited States
Ablexis's Keywords
mood_badFeed is empty.
Add a review